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ABSTRACT 
 
EFFECTS OF RAPAMYCIN ON THE EARLY DEVELOPMENT OF     
ZEBRAFISH (Danio rerio) 
 
Cem KUŞÇU 
 
M.Sc. in Molecular Biology & Genetics 
Supervisor: Dr. Özlen KONU 
JULY 2004, 77 pages 
 
Rapamycin, isolated from the soil bacteria Streptomyces hygroscopicus as an antibiotic, 
previously was shown to have negative effects on the  immune system, cancer 
development, and cell cycle using different model organisms. Specific effects of 
rapamycin on  the TOR  protein activity also was determined by these previous studies. 
In general, TOR  is a kinase that play an important role in the transmission of the signals 
from growth factors and amino acids to proteins involved in translation processes. In 
spite of the increasing popularity of zebrafish (Danio rerio) as a model organism in the 
developmental biological studies, no previous study about the effects of rapamycin on 
zebrafish exists in the literature. In the present thesis, zebrafish TOR (DrTOR) gene 
structure was first characterized in silico and then compared in terms of its homology 
with the mammalian TORs at the cDNA and protein levels.  Expression of DrTOR was 
shown at different embryonic/larval stages and in different tissue samples. Furthermore, 
different doses of rapamycin were given to the embryos during the early developmental 
time (2, 3, 4, 5 dpf). Based on the morphometric analyses, rapamycin concentrations 
greater than 1 µM caused a significant reduction in the larval size.  Additionally, 20 µM 
rapamycin significantly and completely abolished any larval growth supposed to take 
place during this time period. In the 20 µM rapamycin experiment, also a retardation in 
the pigment cell (melanocyte) and cranial cartilage development was observed. 
Expression profiles of the mitfA and  DrTOR were analyzed by using the real-time RT-
PCR. While DrTOR expression was upregulated (3.5 fold) by 20 µM rapamycin, mitfA 
expression was downregulated (% 40). Finally, a siRNA designed against the TOR gene 
was tested for its inhibitory activity when given to embryos in a solution. 
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ÖZET 
RAPAMYCIN’IN ZEBRA BALIĞININ (Danio rerio) ERKEN GELİŞİM 
DÖNEMİNDEKİ  ETKİLERİ 
 
Cem KUŞÇU 
 
Master Tezi, Moleküler Biyoloji ve Genetik Bölümü 
Tez Yöneticisi: Dr. Özlen KONU 
Temmuz 2004, 77 sayfa 
 
Streptomyces hygroscopicus adlı toprak bakterisinden izole edilmiş olan rapamycin, 
hücre bölünmesi, bağışıklık sistemi ve kanserli hücrelerin gelişimi üzerinde olumsuz 
etkilere sahip olduğu değişik model organizmalar üzerinde gösterilmiş bir antibiyotiktir. 
Rapamycinin TOR proteininin aktivitesi üzerindeki özgün etkileri de yapılan bu 
çalışmalar sonucu belirlenmiştir. TOR proteini, genel olarak, hücre içerisinde amino 
asitlerden ve büyüme hormanlarından gelen sinyallerin translasyon mekanizmasında 
öncül rol oynayan proteinlere iletilmesinde görevli bir kinazdır. Zebrabalığı (Danio 
rerio) özellikle gelişim biyolojisinde yaygın olarak kullanılan bir model organizma 
olmasına rağmen, rapamycin’in zebrabalığı üzerindeki etkilerine dair bir çalışma 
literatürde henüz yer almamaktadır. Bu tez çalışmasında öncelikli olarak zebrabalığı 
TOR (DrTOR) geninin in silico (biyoinformatiksel) gen sekansı bulunmuş ve daha sonra 
cDNA ve protein seviyesinde diğer memeli TOR sekansları ile homoloji karşılaştırması 
yapılmıştır. DrTOR geninin embriyonik/larval dönemlerde ve erişkin balığın farklı 
dokularında ifade edildiği gösterilmiştir. Rapamycin erken gelişim döneminde (2., 3., 4., 
5. gün) farklı konsantrasyonlarda verilmiştir. Morfometrik incelemelere dayanarak, 1 
µM’dan yüksek konsantrasyonların larvaların boylarında küçülmeye sebep olduğu 
gösterilmiştir. 20 µM lık dozun ise larvaların boylarında gerçekleşmesi gereken 
büyümeyi tümüyle durduğu istatiksel yöntemler kullanılarak  tespit edilmiştir. 20 µM 
rapamycin verilen embriyoların pigment hücreleri (melanosit) ve kafadaki kıkırdak 
dokularının gelişiminde de gerileme görülmüştür. Real–time RT-PCR kullanılarak 
DrTOR ve mitfA genlerinin mRNA ifade profilleri incelenmiştir. 20 µM rapamycin 
verilen embryolarda DrTOR mRNA ifadesi 3.5 kat artarken, aynı embriyolarda mitfA 
ifadesi % 40 azalmıştır. Son olarak, DrTOR’a karşı dizayn edilen bir siRNA embriyolara 
solüsyon içerisinde verilmiş ve bu siRNA’nin gen ifade engelleme kapasitesi test 
edilmiştir.  
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1. INTRODUCTION 
 
 
1.1. ZEBRAFISH AS A VERTEBRATE MODEL ORGANISM  
 
The Zebrafish (Danio rerio) is a tropical freshwater fish from Northern India 
whose developmental was first studied by Hisoaka & Battle (Hisoaka et al., 1958).  In 
the early 1980s, zebrafish has been proposed as a model organism by George Streisinger 
(Streisinger et al., 1981) based on the utility of zebrafish in the establishment of 
homozygous lines, and the availability of mutants, whose numbers reached to thousands 
in the recent years.  Nowadays, a large number of laboratories use zebrafish as a model 
organism in their developmental and functional genomics studies (http://zfin.org/ZFIN).  
Furthermore, although not yet complete, annotated zebrafish genome sequences and 
ESTs are publically available (www.ensembl.org). 
 
Zebrafish is a vertebrate organism thus is more closely related to humans in 
comparison with other commonly used model organisms, such as Drosophila and C. 
elegans.  Because of this close relationship, many biological traits, including gene 
function, embryonic development, anatomy/physiology, and behavior are similar 
between the fish and human.  Furthermore, zebrafish is an excellent model organism due 
to several other characteristics that it possesses: 1) The zebrafish is relatively small in 
size thus easy to maintain; 2) It produces large numbers of offspring, and the fertilization 
is external; 3) Zebrafish embryonic development is short in length relative to that of the 
mammals such that the basic body plan is shaped within the first 24 hours where the 
same process takes about 9 days in mice (Lardelli et al., 2000); 4) Zebrafish organs 
highly resemble those of the mammalian; 5) The embryos are relatively large (radius = 
0.5 mm) allowing for easy embryonic manipulation, e.g., microinjection; 6) The 
embryos are transparent making possible to mark and observe the development and 
pathology of internal organs, such as the brain, heart and muscle; 7) Finally, the rapid 
growth and global interactivity of the zebrafish community provide researchers with 
large amount of biological knowledge and molecular resources.  Indeed, zebrafish, with 
more than 2000 characterized mutants, has become one of the most preferred models in 
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studying human disease, e.g., hematopoiesis (Brownlie et al., 1999), and melanoma 
(Widlund et al., 2002). 
 
1.1.1. Embryonic Stages of Development  
 
Embryonic stages, which last ~3 days, include the events of fertilization all 
through the hatching process from the chorion.  In the first day, zygote, cleavage, 
blastula, gastrula and segmentation periods are seen; pharyngula period occurs at day 2 
while hatching period takes place at around day 3 (Table 1). The developmental stages 
are temperature dependent.  
 
        
 Table 1.1 Embryonic stages of zebrafish 0-72 hours embryonic stages of zebrafish are 
shown including a brief description for each stage (Kimmel et al., 1995; Grandel et al., 
1998).  
Zygote period (0-3/4h hpf): 
It starts with the fertilization of the oocyte 
and ends after the first cell cleavage at 
about 45 min.  An important feature of this 
1-cell stage is the movement of the non-
yolky cytoplasm towards the animal pole 
followed by initiation of the blastodisc’s 
separation from the yolk granules in the 
vegetal pole. 
 
                                                                    
1-cell stage ( ¼ hpf)   
Cleavage Period (3/4h -2 ¼h): 
After the first cell cleavage, the two 
blastomeres divide synchronously every 
15-minute. After the 6 meroblastic 
divisions, embryo reaches a 64 cell-stage. 
Cleavage period includes the 2-cell, 4-cell, 
8-cell, 16-cell, 32-cell stages ending with 
the 64-cell stage. 
               
                                                                   
2-cell stage (3/4 hpf)   64-cell stage (2 hpf) 
Blastula Period (2 ¼ h- 5 ¼h): 
It begins with the 128-cell stage and ends 
around the 14th cell division when 
gastrulation starts. During the blastula 
period several events take place: the 
formation of yolk syncytial layer, 
asynchronous division leading to a cell 
mound on the yolk, formation of the dome, 
and cellular rearrangements leading to 
epiboly. 
               
                                                                   
128-cell stage                   dome stage            
(2 ¼ hpf)                           (4 1/3 hpf) 
Gastrula period (5 ¼ h-10h): 
In zebrafish, the involution, convergence 
and extension of the cells at the deep layer 
of the blastoderm occurs during 
gastrulation. 50% epiboly stage, i.e., half 
of the yolk is covered by the blastoderm, 
marks the beginning of gastrulation.  
During the shield stage, neural crest is 
induced (Manual et al., 2002). Epiboly 
continues around the yolk reaching 80% 
and 100% before the tail bud stage. 
                
                                                                 
50% epiboly (5 ¼ hpf)    tail bud (10 hpf) 
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Segmentation period (10h-24h): 
Formation of the somites, used as markers 
of development, characterizes the 
segmentation period.  Somites are 
produced every 30 min (at 28.5 °C) by the 
myotome cells.  At 1-somite stage, the 
arrow indicates the first somite. At 5-
somite stage, the regions that will lead to 
the brain and optic vesicles become visible 
whereas at 15-somite stage, the four sub-
divisions of the brain, extension of the tail, 
notochord and yolk extension are visible.  
At 20-somite stage otic vesicle formation 
is completed. 
                  
                                                                   
1-somite (10 1/3hpf)      20-somite (19 hpf) 
Pharyngula period (24h-48h): 
This period is highly informative in the 
comparative developmental biology 
studies since the embryo has a body axis 
with somites, notocord, and the brain.  In 
addition, other structures, such as fins and 
pigment cells start forming, and the 
heartbeat is detectable.  Pharyngula period 
refers to pharyngeal arches.  Among these 
arches, the first two form the jaw structure, 
and the remaining five form the gills.  The 
head-trunk angle (HTA), which is the 
angle between the head of embryo and its 
trunk, used for staging, and should be 50 at 
the end of this period.   
                    
                                                                     
Prim 5 stage                       high-pec stage 
(24 hpf)                                  (48 hpf) 
Hatching Period (48h-72h): 
Hatching is asynchronous in the zebrafish, 
i.e., occurs at different times between 48 
and 72 hours. Embryos are named the 
larvae after hatching.  In this period, the 
jaw, gill arches and the pectoral fins are 
formed. The first two arches contribute to 
the protruding mouth. The branchial arches 
(corresponding to the pharyngeal arches 3-
6) together form the gill but the last 
pharyngeal arches possess the pharyngeal 
teeth. 
                          
Long pec (48 h)    Protruding mouth (72 h)   
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1.1.2. Developmental Genetics 
 
The development of a complex, multicellular organism from single cell is the 
most fascinating event in nature.  In 1980s developmental genetics studies took a turn 
with the identification of mutant genes affecting the segmentation in Drosophila eggs 
(Nüsslein-Volhard et al., 1980) followed by other studies in different model organisms.  
Later, developmental geneticist focused on the link between the cancer and 
development. Cancer has been suggested as a developmental disorder (Dean et al., 1998) 
since many genes that play a key role in development might be involved in cancer.  For 
example, Wilms' Tumour (WT), a relatively common childhood kidney cancer, is a good 
example.   WT1 gene plays a role during kidney development and also in kidney 
function in adults; mutant version of this protein causes kidney cancer (Kent et al., 
1995). 
 
Another important signaling pathway during the development is the Wnt 
signaling, which regulates the cellular proliferation, morphology, motility, fate, axis 
formation and organ development (Kikuchi et al., 2003).  Mutations in the members of 
the Wnt pathway may cause different cancers depending on the mutant gene, i.e., APC 
mutations, colorectal cancer (Kolligs et al., 2002); high B-catenin overexpression, 
cutaneous lymphomas (Bellei et al., 2004).  Wnt-signaling pathway has also a role in the 
melanocyte differentiation, and this interaction has been shown on the zebrafish model 
(Winlund et al., 2002).  The microphtalamia-associated transcription factor (MITF) is a 
down-stream target of the Wnt signal.  The expression of the MITF (human) and mitfA 
(zebrafish) is required for the differentiation of the melanocytes from the neural crest 
cells.  Studies on the melanoma patients shows that expression of the MITF is observed 
in the neoplastic growth of the melanoma as in the normal development (Winlund et al., 
2003; Poser et al., 2004).  Accordingly, understanding of gene regulation during 
development might help further identification of candidate genes carrying oncogenic 
potential.  
 
 
 
1.1.3. Neural-crest Derived Structures 
 
Neural crest cells bilaterally arising at the margins of the neural tube, occupy the 
border between the neural and non-neural ectoderm.  Neural stem cells give rise to 
intermediate precursors, which then gain more specialized fates to become differentiated 
cells such as cartilage, neurons, glia and melanoblasts (Fig. 1; Douarin et al., 2003; 
Nieto et al., 2001).  Several members of the Wnt family, fibroblast growth factor (FGF), 
and bone morphogenetic protein family (BMP) have been known to play important roles 
in the formation of neural crest and the delamination of the cells from neural crest 
(Christiansen et al., 2000).  Two kinds of neural crest cells that exist are: 1) 
ectomesenchymal, i.e., cartilage, bone and adipocyte; and 2) non-ectomesenchymal, i.e., 
pigment cells, neurons and glial cells of the peripheral nervous system, and endocrine 
cells (Douarin et al., 2003).  As in other vertebrates, neural crest induction begins during 
gastrulation period in the zebrafish embryo; and this stage is equivalent to the 6-hpf 
embryo stage in which embyros move into the shield stage from that of the 50% epiboly 
(Manual et al., 2002).
 
Fig. 1.1 Specialization of different cells from multipotent stem cells of the neural crest 
(from Douarin et al., 2003). 
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1.1.3.1. Melanocytes 
 
The three main pigment cell types (i.e., chromatophores) are the black 
melanocytes, yellow xanthopores and silvery iridophores in zebrafish. Pigment cells are 
derived mostly from the neural crest, but another source for them also exists, i.e., the 
RPE (retinal pigment epithelium, only melanocytes; Kelsh et al., 2000). Melanocytes, 
placed bilaterally, become detectable in the zebrafish embryos at around 24 hours 
(beginning of the pharyngula period), which later form the three horizontal melanophore 
stripes along the trunk. Melanocytes contain a special organelle of endosomal origin, 
called melanosome where melanin is synthesized from tyrosine by using tyrosinase 
(Lister et al., 2002). Development of the melanocyte depends on the activity of Wnt 
signaling during the delamination process of the unipotent neural crest cells (Jin et al., 
2001; Dorsky et al., 1998; Dorsky et al., 2000). For example, high levels of Wnt-1 and 
Wnt-3 expression characterize the neural crest cells that will assume the melanocyte fate.  
On the other hand, BMP works antagonistically to the Wnt pathway repressing 
melanogenesis but permitting the neural and glial cell differentiation (Jin et al., 2001). 
 
1.1.3.2. Cartilage 
               
Cartilage differentiation occurs in the ectomesenchymal cells of the neural crest.  
Cartilage is made up of two cell types: the chondrocytes that exist in the matrix and the 
perichondrial cells found in the enveloping mesenchyme of the organ (Kimmel et al., 
1998). For zebrafish, most of the cartilage studies are performed on the head structures, 
such as, the jaws and  the branchial arches (Schilling et al., 1996).  
               
 
Fig. 1.2 The components of the pharyngeal skeleton. 
 Branchial arches 1-5 
  palatoquadrate 
  ceratohyal 
  hyosympletic 
     Mackel’s cartilage 
 There are seven pharyngeal arches in the zebrafish head structure; first 
pharyngeal arch is called the mandibular arch, which is composed of Meckel’s cartilage 
forming the lower jaw and the palatoquadrate forming the upper jaw of the mouth. 
Second pharyngeal arch is called the hyoid, which consists of hyosympletic and 
ceratohyal arches (Piotrowski et al., 1996).  Hox genes, mainly expressed in the 
rhombomeres, control the specification of neural crest cells to become the cartilage. 
Some of the Hox genes are specific for certain individual arches, e.g., Hoxa2 is 
responsible for the hyoid (Piotrowski et al., 1996). The primary component of the 
cartilage is the col2a1 protein, a major collagen. During chondrocyte differentiation, 
matrix structure around the chondrocyte is composed of the col2a1. For example, the 
jellyfish (jef) mutant of zebrafish is characterized by several structural abnormalities in 
the cartilage elements of neurocranium, pharyngeal arches, and the pectoral girdle (Yan 
et al., 2002).  Further studies indicated that jef phenotype is due to a mutation in the 
sox9a gene, which directly regulates the expression of the col2a1 (Yan et al., 2002).  
Therefore sox9a/jef is necessary for both the condensation and differentiation of the 
cartilage.  
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1.1.4. Pleitropic effects  
  
All three structures mentioned above, i.e., the melanophores, pharyngeal skeletal 
elements, and the glial cells, originate from the neural crest cells.  Therefore, a mutation 
or environmentally induced change in the expression of a candidate gene involved in the 
neural crest cell fate determination, differentiation, migration, and/or survival may lead 
to multiple phenotypic consequences.  Indeed, a recent study has shown that defects in 
the trancription factor AP-2a result in the reduction of the embryonic melanophores, as 
well as in various abnormalities in pharyngeal skeleton and the autonomic nervous 
system (O’Brien et al., 2004).   
           
1.2.  FRAP/TOR SIGNALING NETWORK 
 
TOR is an acronym for the “target of the rapamycin”. After being discovered by 
Heitman and his group 10 years ago (Heitman et al., 1991), TOR function was first 
characterized in yeast.  Later, it was found that TOR protein structure is highly 
conserved among different organisms.  In short, TOR is a member of a large protein 
family of PIKK (phosphoinositide kinase-related kinases) that responds to the various 
intracellular and extracellular signals for cellular growth and cell cycle regulation. Other 
members of this family include PI-3K, ATM (Ataxia Telangiectasia Mutated), 
ATR/FRP (Ataxia Telangiectasia Related), and DNA-PKC (DNA-activated protein 
kinase, catalytic subunit). All these proteins possess highly homologous protein kinase 
domains at their C-termini (Rohde et al., 2001).  Besides the C-terminal kinase activity, 
TOR also has other important domains for its function; 1) HEAT domains to support a 
large surface area by an extended superhelical structure for protein-protein interactions 
(Perry et al., 2003); 2) FAT and FATC domains that lie on both sides of the kinase 
domain to maintain the kinase activity; 3) a repressor domain that exists near the FATC 
whose absence cause an increase in TOR kinase activity (Sekulic et al., 2000); and 4) an 
FRB domain near the kinase domain with a function of inhibition of TOR activity after 
binding with FKBP12/rapamycin complex ( Fingar et al., 2004).  
 
Fig.  1.3  Multiple domains of the Human TOR (Fingar et al., 2004)  
   
          Importance of TOR arises from its regulatory kinase activity in various signaling 
pathways. In the upstream of TOR, there are proteins involved in the regulation of the 
nutritional and mitogenic signals, i.e., insulin/IGF receptor signaling, PI3K, PTEN, 
Akt/PKB, TSC1 and TSC2 (Tuberous Sclerosis Complex 1 and 2), and Rheb (Ras-
homolog enriched in brain) (Oldham et al., 2003; Fingar et al., 2004). Once the signal 
arrives at the TOR protein, TOR transmits the growth and proliferation signal to its 
downstream via binding to a scaffold protein, RAPTOR (Hara et al., 2002).  Recent 
studies identified two important genes in the translational mechanism that is directly 
linked to the kinase activity of the TOR protein.  1) 4E-BP (eukaryotic initiation factor 
4E binding protein), when not phosphorylated by TOR, competes with eIF4G 
(eukaryotic initiation factor 4G) to bind the eIF4E (eukaryotic initiation factor 4E), thus 
reducing the efficiency of translation; and 2) p70S6K (ribosomal protein S6 kinase), 
when activated by TOR, increases the efficiency of the translation of mRNA carrying 5’ 
oligopyrimidine tract (5’ TOP mRNA; Tereda et al., 1994). When TOR is active, the 
eIF4F complex (i.e., eIF4E, eIF4G, eIF4A) is efficiently formed; and ribosomes then are 
recruited to the mRNA (Gingras et al., 2001).  
 10
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Fig. 1.4 Upstream and downstream components of TOR. 
 
 
1.3 RAPAMYCIN AS AN INHIBITOR OF FRAP/TOR 
 
Rapamycin (Sirolimus) is a lipophilic macrolide that is produced by the soil 
bacteria, Streptomyces hygroscopicus (Fig. 1.5). Its G1-arrest induction, anti-cancer, 
anti-fungal and immunosuppressive effects make rapamycin a potential drug for the 
investigation of the cell proliferation, growth and development (Grolleau et al., 2002).  
Rapamycin can be administered via multiple routes: 1) organisms may be immersed 
inside a solution/medium that contains rapamycin; or 2) rapamycin may be injected into 
the embryo or larvae using a microinjection apparatus.  Immersion method works well in 
the yeast, Drosophila models and in mammalian cell cultures.   
 
 
 
 
PIP2 PIP3 Akt(PKB) TSC1&2 
PTEN 
Rheb 
mTOR 
rapamycin 
raptor 
S6K 4E-BP 
Cell proliferation, 
    protein sysnthesis 
eIF4E 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 1.5 Rapamycin chemical structure 
 
Heitman et al. (1991) studied the rapamycin-resistant yeast mutant, and found 
that the FRP1 gene, whose product is FKBP12, was absent in most of the resistant yeast. 
Although initially FKBP12 was thought of as a target gene for rapamycin-resistance, 
later the real target was identified as TOR. Accordingly, FKBP12 is a non-essential gene 
product yet its presence in the cell is necessary for the action of the rapamycin on its 
target protein.  Mechanistically, rapamycin first binds to FKBP12; then the resulting 
protein-drug complex inhibits TOR (Heitman et al., 1991). TOR gene that contains an 
FRB (FKBP-Rapamycin-Binding) domain lies between the kinase domain and FAT 
domain in the C-terminal side. Once the rapamycin-FKBP complex binds to the FRB 
domain, the kinase domain of the TOR becomes inactive thus preventing activation of 
the downstream elements in the TOR signaling pathway. 
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1.4. MORPHOLOGICAL AND MOLECULAR EFFECTS OF FRAP/TOR 
INHIBITION 
 
TOR pathway is important for the proliferation of the cells and also growth of the 
organism.  Previous studies performed on the yeast and more complex eukaryotic 
organisms show us the necessity of this pathway for cellular homeostasis. TOR studies 
initially were performed on yeast; more recently, morphological and molecular effects of 
TOR have been investigated by using other important model organisms such as C. 
elegans, D. melanogaster.  TOR function has been studied either by using mutant strains 
or using a pharmacological approach, such as, administration of rapamycin. Yet, no TOR 
study exists for zebrafish in the literature. 
 
1.4.1. S. cerevicea 
            
Organisms adjust their growth according to the nutritional cues that they detect 
in their environment. In this nutrient-sensitive intracellular regulatory network, TOR 
plays a central role.  In the budding yeast, S. cerevicea, there are two TOR complexes, 
but only one is sensitive (TORC1) to rapamycin (Loewith et al., 2002). TOR functions 
in growth processes by 1) positively regulating genes with roles in ribosome biogenesis; 
and 2)  negatively regulating those required for the transcription of stress induced genes 
(Thomas et al., 2004).  
 
The molecular mechanism of the TOR with respect to the nutrients depends on 
the activation status of the PP2A, an important phosphatase in the yeast. TOR maintains 
the PP2A in its repressed state so Rtg2, Ure2 and 14-3-3 become active; ribosomal genes 
are transcribed; and the transcription factors of the stress-induced genes are repressed. 
When TOR is inhibited by nutrient limitation or rapamycin, PP2A becomes active and it 
inhibits the function of the Rtg2, Ure2 and 14-3-3, so stress induced genes are activated 
after the import process of the transcription factors, Rtg1, Rtg3, Gln3, Msn2, and Msn4 
(Loewith et al., 2002; Rohde et al 2001) (Fig.6). 
Since FRAP/TOR inhibition produces very similar phenotypes to starved yeast, 
FRAP/TOR acts as a regulator of nutrient-sensing pathway.  Starvation has different 
kinds of effects on many regulatory pathways for yeast: 1) sporulation, 2) glucose 
activation for the hexose transport regulation; 3) diauxic shift for the regulation of 
fermentable carbon, 4) nitrogen discrimination for quality of nitrogen, 5) nitrogen 
starvation for the lack of nitrogen. Hardwick et al .(1999) examined the above regulatory 
pathways in order to decipher the potential role of rapamycin in nutrient-sensitive 
signaling.  They used yeast microarrays that contain 6220 ORFS and found that while 
three of nutrient-sensitive pathways (general amino acid control, sporulation, nitrogen 
starvation patway) were not under the control of rapamycin, thus TOR signaling, the 
other three (i.e., glucose activation pathway, diauxic shift, nitrogen discrimination 
pathway) were strongly regulated  by the rapamycin (Hardwick et al., 1999). 
 
 
  
 
Fig. 1.6 Effects of TOR on the import process of the transcription factor inside the 
nucleus (Rohde et al., 2001). 
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1.4.2. C. elegans 
          
C.elegans is insensitive to the rapamycin; therefore studies dealing with TOR 
had to be performed by using RNA interference methodology and TOR mutants.  The 
insensitivity to rapamycin may arise from the fact that C. elegans has a cuticle, which 
may prohibit the entrance of the rapamycin into the cells (Long et al., 2002).  
Experiments done by Long et al. (2002) for the CeTOR mutant alleles showed that 
CeTOR-deficient animals exhibited similar phenotypes to those that were starved.  
However, CeTOR deficiency caused more hazardous effects, i.e., developmental arrest at 
the L3 larval stage, defects in the formation of intestinal lysosome and intestinal vesicles 
(Long et al., 2002). In another study by Vellai et al. (2003), absence of TOR resulted in 
an extended lifespan in C.elegans in about two fold.  The involvement of TOR in ageing 
supports the interaction between TOR, nutrition, longevity, and metabolism. 
   
1.4.3. D. melanogaster 
 
As in C.elegans, an extension in the lifespan was observed in Drosophila upon 
inhibition of TOR function (Kapahi et al., 2004). In Drosophila, it was found that the 
tumor suppressor genes, TSC1 and TSC2 (tuberous sclerosis complex 1 and 2), inhibited 
the function of TOR, so overexpression of TSC1/2 or the downregulation of TOR 
resulted in an increase in the lifespan. This increase also was influenced by the 
nutritional status of Drosophila as in C. elegans. When these two tumor suppressor 
genes were inhibited by high levels of amino acids, TOR activated the genes involved in 
the ribosome biogenesis and translational mechanism.  In addition to the aminoacid 
level, insulin and IGF produced similar effects on the TOR activation through the PI3K 
signaling (Oldham et al., 2003) since insulin signaling passed through from PI3K to 
TOR via PKB/Akt (Miron et al., 2003).  Drosophila studies also showed the importance 
of TOR signaling in body size regulation. Mutation in TOR caused developmental arrest 
during the larval stages of Drosophila, such that mutant organisms only reached 24% of 
size of the wild type (Zhang et al., 2000).       
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1.4.4. M.musculus 
 
One mutant type of the mouse is the flat-top mutant, which exhibited severe 
defects especially in its brain structure.  Furthermore, flat-top mutants are relatively 
smaller and short-lived (i.e., death occurs within 13 days) when compared with the wild 
type embryos.  Hentges et al. (2001) studied these mutant loci were homologous to those  
located on the human chromosome 1p35-36 where TOR lies. Furthermore, rapamycin 
treatment phenocopied the effect of the flat-top (mutant TOR) embryo. 
 
 
1.5. FUNCTIONAL GENOMICS 
 
Recent advances in the molecular biology and genetics fields, such as whole 
genome sequencing, the development of gene knock-out and knock-down technologies, 
as well as the availability of high throughput expression analysis by microarrays, have 
accelerated the discoveries made in regards to functional genomics.  Extensively 
annotated complete sequences of many model organisms, such as, C. elegans, D. 
melanogaster, M. musculus, have been published, allowing for comparative evolutionary 
analyses of genomes.  Functional genomics studies in invertebrates C.elegans and D. 
melanogaster have produced vast amount of information on the function of clusters of 
genes responsible for development and pathogenesis (C. elegans: Ashrafi et al., 2003, 
obesity; Pothof et al., 2003, mutator genes and cancer; D. melanogaster: Pagliarini & 
Xu, 2003, metastasis; Boutros et al. 2004, growth and viability).  Zebrafish, although its 
genome is not fully sequenced, has been highly promising as a model organism in 
functional discovery due to its vertebrate status.  Successful knockdown studies in fish 
and amphibians have been mostly based on the use of morpholinos (Heasman et al., 
2000; Heasman et al., 2002) but recently siRNA technology also became available 
(Boonanuntanasarn et al., 2003; Dodd et al., 2004). These studies proved useful in 
identification and functional studies of zebrafish genes that played key roles in 
developmental processes and diseases that are common among all vertebrates.  For 
example, Langheinrich et al., 2002 examined the zebrafish genes involved in DNA 
damage-induced apoptosis using morpholinos, thus demonstrating the potential zebrafish 
has as a vertebrate cancer model.  Furthermore, functional genomics studies have began 
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to ease the path for novel gene discovery, which indeed is a difficult task for the fact that 
gene networks cross-talk with each other, extensively.     
 
 
 
1.6. CANDIDATE GENES IN FRAP/TOR SIGNALING 
 
As it is explained in the part 1.2, TOR lies in center of the nutrient and growth 
signaling mechanism of the cell, and the two important genes that are located 
downstream of the TOR are p70S6K and the 4EBP, which act as stimulatory proteins in 
the translation processes. Alteration in the expression profile of these developmental 
genes during embryogenesis due to the activation status of TOR is very reasonable since 
during development, de novo protein synthesis is required.  Accordingly, we aimed to 
find computationally the genes with expression profiles similar to that of TOR for 
further characterization of the effects TOR inhibition by rapamycin in zebrafish. 
 
1.6.1. Vxinsight as a tool for candidate gene discovery 
 
VxInsight is a powerful visualizing program to evaluate the microarray data on a 
global scale. Stuart et al. (2003) used more than 3000 microarray experiments from 
SMD (Stanford Microarray Database) from  H. sapiens, D. melanogaster, C. elegans 
and S. cerevisiae, to construct a gene co-expression network. They solved the 
nomenclature problem of the homologus genes from these four different organisms by 
using a new concept called the meta-gene (MEG).  In their construction, there were a 
total of 6307 meta-genes derived from 6591 human, 5180 worm, 5802 fly, and 2434 
yeast genes.  Each meta-gene was then placed on the coordinate system of a 2-
dimentional map of the VxInsight, so that one could localize the gene of interest as well 
as its expressionally co-regulated neighbors. FRAP/TOR with a meta-gene number of 
MEG-1077 were found to be connected to a network of genes through HIPK; among 
several genes that seemed promising for further study, here in we focus on MITF (MEG-
1228) which is  involved in melanocyte differentitation from neural crest cells. 
 
 
1.6.2. mitfA 
 
MITF (microphthalmia -associated transcription factor) is a basic helix-loop-
helix-leucine zipper protein, with a significant role in establishing the melanocyte fate 
from neural crest cells (Winlund et al., 2003). Identification of the nacre mutation in 
zebrafish helped to elucidate the mechanisms of melanocyte formation in zebrafish, 
because nacre embryos did not show the characteristic pigmentation pattern of the 
embryo except in the retina of the eye. The aberrant gene in nacre was found to be an 
ortholog of the mammalian Mitf by Lister et al (1999), and named as mitfA because 
zebrafish genome has a paralog of mitfA, i.e., mitfB, which compensated the function of 
the mitfA on the pigmentation of eye in nacre mutant (Lister et al., 2001; Lister et al., 
2002).  Defects in MITF also lead to abnormalities in the coat color of mouse 
(Hodgkinson et al., 1993), and deafness and the Waandenburg Syndrome in humans 
(Widlund et al., 2003).  
Dorsky et al. (2000) has showed that mitfA, integral to the melanoctye formation, 
has a Tcf/LEF and B-catenin binding site on its promoter.  Once activated by the Wnt 
signaling, mitfA subsequently activates the major pigment enzymes: tyrosinase, 
tyrosinase related protein (tyrp1), and dopachrome tautomerase (dct), also known as 
tyrp2. These pigment enzymes convert the tyrosine into melanin in the specific organelle 
of the melanocyte that is called as melanosome.  
 
                        tyrosinase          tyrosinase 
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mitfA               tyrp1  
             dct                  melanin         melanoblast          melanocyte (melanophore) 
                                     (Inside the melanosome) 
 
  Besides Wnt signaling, sox10 is required as another upstream gene of the mitfA 
regulation (Elworthy et al., 2003).  Kelsh et al. (2000) identified another key gene 
essential in the melanoctye formation, c-kit which lies downstream of the mitfA 
(Winlund et al., 2003).  However c-kit also was shown as the translational activator of 
the mitfA (Winlund et al 2003) that suggested the presence of a potential auto-regulatory 
mechanism between the mitfA and c-kit.  The general scheme for the Mitf expressional 
regulation was graphically summarized in Fig. 7. 
 
 
Fig. 1.7 Role of mitfA in pigmentation 
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2. AIM OF THE STUDY 
 
 
2.1. AIM 
 
 
FRAP/TOR expression plays an important role in the cell cycle regulation and 
nutritional control of translation. Rapamycin, as a specific inhibitor of FRAP/TOR at the 
protein level, allows for characterization of the mechanisms involved in this pathway. 
Effects of rapamycin have been studied in many model organisms, including S. 
cerevicea, C. elegans, D. melanogaster, M. musculus, as well as in different cell lines. 
Our primary aim was to investigate the FRAP/TOR function in the zebrafish embryos, 
whose TOR signaling has not been previously studied. 
 
 
2.2. STRATEGY 
 
 
In order to study FRAP/TOR function in zebrafish, we used a strategy involving 
lack of function studies was used. Thus we aimed to inhibit the FRAP/TOR function a) 
at the protein level by using rapamycin; and b) at the transcriptional level by using 
siRNA designed for DrTOR. Accordingly, we attempt to show the effects of TOR 
inhibition by using real time RT-PCR, morphometrics, and histological techniques. 
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3.   MATERIALS AND METHODS
 
3.1. ANIMALS 
 
Zebrafish (Danio rerio) used in the presents experiments were purchased from a 
pet-shop. The AB strain from University of Oregon at Eugene, OR, USA, also was 
established in the laboratory for further studies. 
 
3.1.1. Maintenance 
3.1.1.1. Aquaria system and water condition 
 
Zebrafish were kept in glass aquaria (50 x 30 x 23 cm), which hold about 30 
liters (6 gallons) of system water. Tap water was allowed to stay for two days before 
being fed into the system.  Each aquarium was equipped with a standard filtering system 
that has a coarse mechanical filter, while providing large surface area for the denitrifying 
bacteria. Five percent of the water was replaced with fresh system water daily, or 
alternatively 1/3 of the tank water was replaced weekly. 
             Illumination period should be 14h light/10h dark for efficient zebrafish 
maintenance and optimal breeding. This cycle was kept constant by using a clock timer. 
Embryos were handled during the dark period if necessary under a red-light lamp for not 
to disturb the fish. 
 . 
3.1.1.2. Housing and feeding 
Adult zebrafish were of 3-4 cm in length; and up to 15 adults were kept in a 30-
liter aquarium.  Adult fish were fed dry food flakes twice per day.  For efficient 
breeding, live food also is necessary; thus fish were fed Artemia nauplia every other 
day.  For hatching the Artemia, inverted plastic bottles with cut-off bottom were used, 
(Fig. 3.1).  5 g of Ocean Salt was added into 200 ml constantly aerated distilled water; 
and temperature was kept at 28.5 °C.  At the end of 48 hours, hatched Artemia were 
collected using a plastic pipette; filtered through paper towels and rinsed by system 
water. 
 
Fig. 3.1 Hatching system. 
 
3.1.2. Breeding 
 
For efficient breeding, fish kept at a constant 14h/10h light/dark regime at 28.5 
°C. Pairs of male and female fish were put in the breeding cages in the afternoon; the 
fertilized eggs were collected in the morning. Zebrafish are photoperiodic in their 
breeding, and produce embryos every morning.  Up to 70 to 300 embryos could be 
obtained per day in our laboratory, and generally ~ 50 to 80% of them were fertilized. 
Unfertilized eggs were discarded immediately while fertilized eggs were transferred into 
a 95-mm Petri dish and washed several times in system water. 
 
3.1.3. Embryo handling 
 
Maximum of 70 embryos were kept in each 95-mm Petri dish in E3 embryo 
medium (5mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4 and 10-5% 
methylene Blue) or in the system water.  Petri dishes were kept in an incubator, set at 
28.5 °C with a 14h light/10h dark illumination period.    In order to treat multiple 
embryos either with rapamycin, siRNA or control solutions, they were transferred into 
the 96-well plates (Fig. 3.2). Within each well, up to 5 embryos were treated by a 
maximum of 250 µl treatment solution.  Embryos were kept in these wells until 6 days 
post fertilization (dpf) since they feed from their yolk.  For the purposes of this thesis, 
embryos were studied until they were 6 dpf while zebrafish older than 6 dpf were kept in 
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200 ml plastic holders with mesh bottoms and were fed baby dry flake (Tetramin baby 
food) until old enough to eat Artemia. 
 
Fig. 3.2 Only 4 wells of the 96-well plate are shown. 
 
 
3.2. STANDARD SOLUTIONS & BUFFERS 
 
3.2.1. 10X TBE electrophoresis buffer 
108 g Tris base 
55 g Boric acid 
40 ml EDTA(0.5 M) 
add dH2O to the 1 liter 
 
3.2.2. 1X TE electrophoresis buffer 
10 mM Tris.Cl (pH 7.4) 
1mM EDTA 
 
3.2.3. DNA loading buffer 
20% glycerol 400 
0.25% bromophenol blue 
0.25% xylene cyanol 
 
3.2.4. 10X FA (formaldehyde agarose) gel buffer for RNA 
200 mM MOPS 
50 mM sodium acetate 
 23
 24
10 mM EDTA 
pH to 7.0 with NaOH 
 
3.2.5. 1X FA gel running buffer 
100 ml 10X FA gel buffer 
20 ml 37% (12.3 M) formaldehyde 
880 ml RNase-free water 
 
3.2.6. 5X RNA loading buffer 
16 µl saturated aqueous bromophenol blue solution 
80 µl 500 mM EDTA, pH 8.0 
720 µl 37% (12.3 M) formaldehyde 
2 ml 100% glycerol 
3084 µl formamide 
4 ml 10X FA gel buffer 
RNase-free water to the 10 ml. 
 
3.2.7. traciane solution (stock) 
400 mg tricaine powder 
97.9 ml dd H2O 
~2.1 ml 1 M Tris (pH 9) 
to use as an anesthetic: 
4.2 ml tricaine stock solution 
~100 ml clean tank water 
 
 
3.2.8. PFA (4%) 
0.8 g paraformaldehyde (powder) 
20 ml PBS 
store at 4 °C in dark , its efficient stability was 2-3 days 
 
 
 25
3.2.9. PBS 
8 g NaCl 
0.2 g KCl 
1.44 g Na2HPO4 
0.24 g KH2PO4 
dissolve in 800 ml dH2O, adjust the pH 7.4 with HCl 
add dH2O to 1 liter 
 
3.2.10. PBT (0.1%) 
40 ml PBS 
40 µl Tween20 
 
3.2.11. neutral 10% formalin 
10 ml (37%) formaldehyde 
0.4 g NaH2PO4 
0.65 g Na2HPO4 
add dH2O to 100 ml, adjust the pH 7.0 
 
3.2.12. DEPC-H2O 
500 µl DEPC (from AppliChem) 
1 liter dH2O 
o/n aeration, autoclave 
 
3.2.13. Alcian blue solutions (0.1%) 
100 mg alcian blue dye (powder) 
70 ml EtOH (100 %) 
30 ml glacial acetic acid 
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3.3. RAPAMYCIN TREATMENT OF EMBRYOS 
Rapamycin (MW: 914.2 g) was ordered from the Calbiochem as 1 g solid 
product (Calbiochem, Germany, Catalog # 553210). This 1 g product was dissolved in a 
200 µl DMSO (dimethlysulphoxide) as a stock solution that has a concentration of 5 
mM; and was stored at -20°C in dark. To decrease the harmful effect of the thawing in 
each use, it was aliquoted as 20 µl samples. Its concentration was then adjusted to 20 
µM, 2 µM and 1 µM by making appropriate dilutions using the system water or the E3 
medium. These solutions with variable concentrations were applied to the zebrafish 
embryos in the wells of a 96-well plate. In each experiment, control solutions were 
prepared by including the same amount of DMSO as found in the rapamycin solutions.  
At 8, 12, 16, 20, 24, 36, and 48 hpf, and 3, 4 and 5 dpf embryos were removed from 
wells; either observed and photographed in the depression slide and/or fixed in 
paraformaldehyde or formalin. 
 
 
3.4. PHENOTYPIC SCREENING METHODS 
 
3.4.1. Morphometric measurements 
 
The zebrafish larvae were examined under the dissecting microscope (Zeiss, 
Stemi 1000; Fig. 3.3). Standard length measurements were taken by using a computer 
program (TPS, SUNY-Stony Brook, http://life.bio.sunysb.edu/morph/) on the digital 
photos (Pretec, DC 1310, 1.3 mega pixels). The coordinates were saved as a text file; 
and standardization of each set of measurements was made by using coordinates from a 
micrometer photograph, separately taken for each sample.  A Matlab® program was 
used to convert the coordinates into Euclidean distances in mm, and statistical analyses, 
i.e., ANOVA and regression also were performed using Matlab® anova1, anovan, and 
regress built-in function (see Appendix A for the code of program ). 
 
Fig. 3.3 Zeiss microscope and incubator at 28.5 °C.  
 
3.4.2. Fixation of embryo/larva 
 
Embryos were anesthetized in the tricaine solution (0.08%, SIGMA, Catalog# 
5040) and then fixed in either parafomaldeyhde or formalin for alcian blue staining. 
Larvae were treated in a PFA solution (4% paraformadehyde in PBS) or buffered 
formalin (10%) for 2 hours at RT or overnight at 4 °C; followed by washing in the PBT 
for 10 min at 4 °C. They were then dehydrated in a MeOH:PBT series (1:3/1:1/3:1) for 
10 min at RT in each solution; and were stored in the 100% MeOH at -20 °C. 
 
 
3.4.3. Cartilage staining and morphology 
 
Paraformaldehyde-fixed larvae were rinsed in the 80% EtOH/ 20 % glacial acetic 
acid. The larvae were then stained in a 0.1% Alcian Blue solution dissolved in 80% 
ethanol/20% glacial acetic acid for 6-8 hours; and de-stained in the 80% EtOH/20% 
glacial acetic acid several times. Larvae were rehydrated gradually in the EtOH/PBS 
series (3:1/1:1/1:3) in dark; followed by bleaching in the 1% KOH/3% H2O2 for about 1 
hour. At the end, they were de-stained in a 0.1% KOH/glycerine series, and were stored 
in the 75-100% glycerol. 
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3.4.4. Melanocyte morphology and distribution 
 
Melanocytes were examined under the microscope for their characteristic larval 
pattern and digital photographs were taken for visualization and presentations. 
 
 
3.5. DETERMINATION OF GENE EXPRESSION 
 
mRNA expression of several genes from embryos, larvae, and various adult 
tissues were quantified. Therefore, total RNA from multiple samples were extracted; 
reverse transcribed into cDNA; and qualitative PCR and/or real-time quantitative PCRs 
were performed on these samples. 
 
3.5.1. Total RNA Isolation from Embryos and Adult Tissues 
 
During RNA isolations, all material and solutions were treated with diethyl 
pyrocarbonate (DEPC) to inhibit the RNase contamination.  Larval and adult zebrafish 
samples were first put into the RNAlater solution or liquid N2. Total RNA isolation was 
performed by using the Qiagen RNeasy Mini Kit or Ambion Totally RNA isolation kit.  
Briefly, samples were removed from RNAlater and put in the RLT buffer, which 
contains 1% B-ME (B-mercaptoethanol). Samples were homogenized in RLT by using 
20 gauge needles. One volume of 70% EtOH was added to the homogenized lysate, and 
mixed well. Up to 700 µl of the sample were added to an RNeasy mini column in a 2 ml 
tube; and centrifuged for 15 s at 10.000 rpm. After discarding the flow-through, 700 µl 
buffer RW1 were added to the RNeasy column, centrifuged for 15 s at 10.000 rpm. After 
discarding the flow-through, 500 µl buffer RPE, which contains 4 times 100% EtOH, 
were added onto the RNeasy column, and centrifuged for 15 s at 10.000 rpm; and this 
was repeated a second time followed by centrifugation for 1 min at full speed.  The 
column was placed in the 1.5 ml collection tube; and 30 µl RNase-free water were 
pipetted on the center of the RNeasy silica gel membrane; and centrifuged for 1 min at 
10.000 rpm. At the end, the elute containing RNA of the sample was stored at -80 °C. 
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Alternatively, RNA was isolated using Totally RNA Isolation Kit (Ambion).  
Samples were removed from the RNAlater and put in the at least 200µl denaturation 
solution and homogenized by using a 20 gauge needle. One volume of the 
phenol:chloroform:IAA was added to the lysate and shaked for 1 min.  The 
lysate/phenol was stored on ice for 5 min then centrifuged for 5 min at the 12.000 rpm at 
4 °C.  The upper aqueous phase was transferred to a new vessel; and 1/10 aqueous phase 
volume of the Sodium Acetate solution was added to the phenol extracted lysate.  Then, 
a volume of acid-phenol:chloroform was added and shaken for 1 min. The lysate/phenol 
was stored on ice for 5 min and was centrifuged for 5 min at 12.000 rpm at 4 °C.  The 
aqueous phase transferred to a new vessel; and one aqueous phase volume of the 
isopropanol was added to the preparation; mixed well; placed at -20 °C for at least 30 
min; and then centrifuged at 12.000 rpm for 15 min. Supernatant was carefully discarded 
and the pellet was washed with the 70% EtOH to remove the residual salts. Finally, the 
pellet was resuspended in the 30-50µl of DEPC Water/EDTA and stored at -80 °C. 
 
3.5.2. Determination of RNA Concentrations by Spectrophotometer 
 
2 µl of each sample were diluted (1:200) with 400 µl DEPC-treated ddH2O. 
Then, the measurements were taken at 260 nm and 280 nm by using the Beckman 
spectrophotometer.  The concentration was calculated by using the formula below given 
below: 
[RNA]=O.D260*40*d.f(200) 
O.D 260/O.D 280 ratio is used the purification quality of the RNA. Most ratios were 
between 1.8 and 2.1, as expected. 
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3.5.3. Denaturing Agarose Gel Electrophoresis 
 
3.5.3.1. Preparation of the FA (formaldehyde agarose) Gel (1.2 %) 
 
1.2 g agarose was added into 10 ml 10 X FA gel buffer followed by the addition 
of the RNase free water to 100 ml. Mixture was heated to melt the agarose then it was 
cooled to 65 °C. 1.8 ml of 37% (12.3 M) formaldehyde; and 1µl of a 10 mg/ml ethidium 
bromide stock solution was added; mixed thoroughly and poured onto the gel support. 
 
3.5.3.2. Preparation of samples for loading 
 
One volume of 5X loading buffer per 4 volumes of the RNA sample (for low 
RNA amounts RNA was diluted in the DEPC–water) was added and mixed; incubated 
for 3-5 min at 65 °C; then chilled on ice; and loaded onto the pre-equilibrated FA gel.  
1X FA gel running buffer was used for equilibration.  The samples were then run at 5-7 
V/cm in 1X FA gel running buffer. The gels were visualized under the U.V light and 
images were analyzed using the Multi-Analyst Software. 
 
3.5.4. cDNA Conversion 
 
After the RNA isolation and measurements, equal amounts of the RNA were 
converted into the 1st strand cDNA by using the Fermentas cDNA kit (Catalog# 1622). 
First, RNA was annealed by the oligodT primers for 5 min at the 70 °C. This mixture 
was treated by an RNase inhibitor for 5 min at the 37 °C. Finally, mixture was treated by 
the MMLV-reverse transcriptase for 1 hour at 42 °C and 10 min at 70 °C. The cDNAs 
were stored at the -20 C. 
 
3.5.5. Primer Design 
Primers were designed by using a software program, the Primer Designer 
Version 2.0 (Scientific and Educational Software). System defaults used were given in 
the Table 3.1 and the following primers were ordered accordingly (Table 3.2): 
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Table 3.1 The default parameters used as primer design criteria by Primer Designer 
Version 2.0. 
%GC                             : 50%-60%  
Tm°C range                   : 55 °C -80 °C 
Hair pin energy cut off : 0.0 kcal 
Dimers: 
Reject if                         >= 3 matches at the 3’ end 
Reject if                         >=7 adjecent homologous bases 
Runs of bases: 
Reject runs if                  >=3 bases any 
Reject runs if                  >=3 G or C at the 3’ end 
 
Table 3.2 Forward and reverse primer sets used to amplify the genes mentioned in the study.   
Primer Name Primer Sequence 
Frap/tor FOR 5’-ACACGCTGCACGCACTGATT-3’ 
Frap/tor REV 5’-CCACCTTCTCCATTAGAGTC-3’ 
Mipep    FOR 5’-AACATCGAGATCCAGCACC-3’ 
Mipep    REV 5’-ACATCCTCAGAGAATTGCAG-3’ 
MitfA     FOR 5’-GACAGAATTAAGGAGCTGG-3’ 
MitfA     REV 5’-AATACGGAGCAGGAGATGTC-3’ 
 
 
3.5.6. RT-PCR 
 
Following the conversion of RNA into cDNA, an RT-PCR reaction was 
performed with the appropriate primers using the cDNA as the template.  PCRs were 
performed in 0.2 ml Thermowell tubes using the Techne PCR machine (Techne, 
ftGENE2D, Cambridge-England). Each reaction contained a total of 25 µl reaction 
volume that includes 1µl cDNA, 10 pmol reverse and forward primer, 0.5 ml dNTP 
(0.2mM of each), 1.5 mM MgCl2, 2.5µl 10X PCR buffer and 1 unit Taq DNA 
polymerase( Fermentas, Catalog# EP0402).  PCRs included an initial heating step at 94 
°C temperature for 5 min, and then a denaturation step was performed at 95 °C for 30 
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min as first step of the 30-35 cycles of the loop. Annealing temperature was the second 
step of the loop (Table 3.3). 
 
Table 3.3 Annealing temperatures optimized for the PCR reactions of the candidate 
genes. 
Primer set Annealing temperature (30sec) 
Frap/tor 60 °C 
Mipep 57 °C 
MitfA 56 °C 
 
      
Elongation was performed at 72 °C for 30 seconds for each primer set. At the 
end of the 30-35 cycles, a final extension at 72 °C for 10 minutes was also performed. 20 
µl of the product was loaded on a 2% agarose gel in the electrophoresis system for 
visualization and characterization of the PCR products. 
 
3.5.7. Real Time RT-PCR 
 
Qiagen Real-Time Kit, which contained SYBR green as a marker dye for 
measurement of PCR yield in each cycle, was used for all reactions. 12.5 µl SYBR- 
green mix, 10 pmol forward and reverse primers, and 1 µl cDNA were mixed in the 
supported 96 well-plate and RNase-free water was added to 25 µl in each well; and 3 µl 
mineral oil was added at the top of the solution to inhibit the evaporation of the product 
from the well. PCR reactions were performed using the BIO-RAD iCYCLER machine. 
For each primer set, PCR program was the same with that explained in the section 3.5.5, 
but additionally iCYCLER reactions included a pre-activation step for the hot-start 
Qiagen Taq DNA polymerase (95 °C for 8-10 min). A melt curve was generated at the 
end of each set of reactions beginning with 55 °C and ending at 95 °C by 0.5 °C 
increments in each 15 second. The expression profiles over the embryonic time course 
were analyzed using sign-rank tests (matlab® sign rank function). Sign-rank test 
compares paired samples (control and rapamycin samples at specific time points) and 
gives a probability value describing the likelihood of having the observed expression 
difference by chance alone.  
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3.6. siRNA TREATMENT 
 
3.6.1. siRNA Design 
 
A 5’ siRNA for the degradation of the target DrTOR mRNA was designed from 
the putative exon 6 of the gene. Candidate siRNA target sequences were determined 
using the tools provided by Qiagen (www.qiagen.com); then analyzed by the blast 
program in the ENSEMBL (www.ensembl.gov) and NCBI (www.ncbi.nlm.nih.gov) 
databases to select those siRNAs with the least possible homology to other sequences in 
the genome.  The selected siRNA sequence was as follows: 
5’-AAGGATGATCGTGTACATGGA-3’, 
 
This target sequence was used to produce the sense and antisense strands (Table 
3.4) by the siRNA template design tool on the website of AMBION (www.ambion.com). 
 
Table 3.4  The sense and antisense sequences for the DrTOR siRNA 
Results: Antisense siRNA Oligonucleotide Template: 
5'- AAGGATGATCGTGTACATGGACCTGTCTC -3' 
Results: Sense siRNA Oligonucleotide Template: 
5'- AATCCATGTACACGATCATCCCCTGTCTC -3'  
 
3.6.2. siRNA Production: 
 
dsRNA was obtained using the siRNA contstruction kit by Ambion (Catalog # 
1620). The manufacturer’s protocols are as briefly described below: 
 
3.6.2.1. Transcription Template Preparation 
            
The sense and antisense template oligonucleotides (DNA) were converted to 
dsDNA using the T7 promoter primer and exo-klenow fragment. 
 
3.6.2.2. dsRNA Synthesis 
Oligonucleotides were used as templates for the in vitro transcription process.  
By using the T7 RNA polymerase, single stranded RNA products for sense and 
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antisense oligonucleotides were obtained, and then these ssRNAs were assembled in the 
same reaction tube overnight at 37 °C to obtain a dsRNA product. 
 
3.6.2.3. siRNA Preparation/Purification 
 
To remove the 5' overhanging leader sequences, leader sequence was digested by 
the single strand specific ribonuclease (RNase). DNA template also was eliminated by 
the DNase treatment in the same digestion buffer. Afterwards, dsRNA were treated by 
the siRNA binding buffer and siRNA wash buffer, finally dsRNA was eluted into RNase-
free water and stored at –80 °C (Fig. 3.4). 
 
3.6.2.4. siRNA Quantification 
.  
siRNA was diluted 100 times in the TE buffer; and its absorbance was measured 
by the spectrophotometer at 260 nm. The absorbance value was multiplied by the 4000; 
and the result was divided by 14 since there are 14 µg of RNA in 1 nmole of an average 
21-mer dsRNA. siRNA was used after the appropriate dilution as a solution. 
 
3.6.3. siRNA Treatment on Zebrafish Embryos 
 
ds siRNA were given to the embryos in 96-well plates, 4-5 embryos were treated 
with the 40 nM, 80 nM siRNA containing E3 medium; a control with no siRNA was also 
present.   
 
  
Fig. 3.4 A simplified schema of the siRNA production by the siRNA construction kit of 
Ambion from www.ambion.com. 
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4.   RESULTS
 
4.1. IN SILICO CONSTRUCTION OF ZEBRAFISH TOR (DrTOR) GENE 
        
FRAP/TOR gene was not fully annotated in any of the genome browsers on the 
WWW until recently. In order to the characterize TOR gene for Danio rerio in silico, 
human, mouse and rat FRAP/TOR genomic sequences were used for the blast analysis to 
find Dr FRAP/TOR in the genome of zebrafish.  At the moment, genome of the 
zebrafish, composed of many supercontigs, is partially assembled on the ENSEMBL 
web site (http://www.ensembl.org/Danio_rerio/). Recently, zebrafish TOR has been 
partially annotated in the ENSEMBL database.  Therefore, the information provided in 
regards to assembled parts of the DrTOR in ENSEMBL also was used. Exon homology 
study involved the comparisons between all known exons of the human, rat, mouse TOR 
genes against the most current version of the zebrafish genome (3b WTSI Zv3, 01 April 
2004). 
 
4.1.1. Exon Homology 
 
The blast analyses of each exon of the mammalian FRAP/TORs against zebrafish 
genome were performed using the ENSEMBL zebrafish BLAST/SSAHA program 
(Table 4.1). 
 
Table 4.1 Chromosomal locations, ensembl ID numbers, and certain features of the 
mammalian TOR genes 
FRAP/TOR 
gene ensembl ID locus 
number 
of 
exons 
transcript 
length 
(bp) 
translation 
length 
(a.a) 
Human 
 ENST00000263936 
chromosome 
1 57 8619 2555 
Mouse 
 ENSMUST00000057580
chromosome 
4 58 7718 2546 
Rat 
 ENSRNOT00000014167
chromosome 
5 58 7653 2550  
 
 
 . 
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Table 4.2 Homology comparisons of human, mouse and rat exons of TOR genes against 
the zebrafish genome.  No hit refers to the absence of any significant homology between 
that particular exon and zebrafish genome for a specified species.  * indicates that no 
homology could be identified by the ENSEMBL blast program, so that sequence 
similarity was calculated by using the clustalW program (http://www.ebi.ac.uk/cgi-
bin/clustalw/). The values whose boxes are marked by the blue color were found in the 
1bp to 34766 bp of the Supercontigfinished 202, other values were calculated according 
to the region on the chromosome 8. 
Human exons 
% 
identity Mouse exons 
%    
identity Rat exons 
% 
identity 
Human exon1 76.47 mouse exon1 no hit rat exon1 74.26 
Human exon2 80.73 mouse exon2 72.79 rat exon2 75.23 
Human exon3 79.13 mouse exon3 76.15 rat exon3 79.57 
Human exon4 78.11 mouse exon4 77.39 rat exon4 77.11 
Human exon5 81.48 mouse exon5 *74 rat exon5 80.74 
Human exon6 75.18 mouse exon6 82.22 rat exon6 75.18 
Human exon7 74.07 mouse exon7 76.34 rat exon7 75.23 
Human exon8 67.21 mouse exon8 78.7 rat exon8 *67 
Human exon9 80.62 mouse exon9 *66 rat exon9 78.29 
Human exon10 81.63 mouse exon10 79.84 rat exon10 81.3 
Human exon11 81.94 mouse exon11 79.59 rat exon11 82.41 
Human exon12 84.54 mouse exon12 84.72 rat exon12 83.09 
Human exon13 81.3 mouse exon13 84.54 rat exon13 79.67 
Human exon14 68.89 mouse exon14 78.86 rat exon14 *67 
Human exon15 78.49 mouse exon15 70 rat exon15 80.85 
Human exon16 77.94 mouse exon16 76.34 rat exon16 78.68 
Human exon17 82.81 mouse exon17 80.15 rat exon17 83.59 
Human exon18 81.2 mouse exon18 82.81 rat exon18 82.4 
Human exon19 *71 mouse exon19 80.8 rat exon19 79.52 
Human exon20 77.51 mouse exon20 80.72 rat exon20 76.92 
Human exon21 74.34 mouse exon21 78.57 rat exon21 79.79 
Human exon22 *71 mouse exon22 77.88 rat exon22 73.01 
Human exon23 81.72 mouse exon23 *71 rat exon23 81.72 
Human exon24 No hit mouse exon24 82.8 rat exon24 no hit 
Human exon25 76.92 mouse exon25 no hit rat exon25 no hit 
Human exon26 77.91 mouse exon26 no hit rat exon26 78.17 
Human exon27 80.27 mouse exon27 77.62 rat exon27 78.53 
Human exon28 84.21 mouse exon28 80.98 rat exon28 78.91 
Human exon29 79.29 mouse exon29 78.23 rat exon29 81.58 
Human exon30 82.29 mouse exon30 81.58 rat exon30 80.71 
Human exon31 *78 mouse exon31 79.29 rat exon31 81.25 
Human exon32 No hit mouse exon32 83.33 rat exon32 79.31 
Human exon33 No hit mouse exon33 87.07 rat exon33 no hit 
Human exon34 No hit mouse exon34 no hit rat exon34 no hit 
Human exon35 72.33 mouse exon35 no hit rat exon35 no hit 
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Human exon36 81.9 mouse exon36 no hit rat exon36 *71 
Human exon37 80.34 mouse exon37 *72 rat exon37 82.3 
Human exon38 87.37 mouse exon38 82.3 rat exon38 83.19 
Human exon39 *77 mouse exon39 83.9 rat exon39 87.38 
Human exon40 75.51 mouse exon40 68.1 rat exon40 73.53 
Human exon41 80.81 mouse exon41 *73 rat exon41 81.63 
Human exon42 80.49 mouse exon42 81.63 rat exon42 78.79 
Human exon43 79.23 mouse exon43 77.78 rat exon43 82.11 
Human exon44 80 mouse exon44 83.74 rat exon44 78.14 
Human exon45 78.86 mouse exon45 78.69 rat exon45 81.48 
Human exon46 *77 mouse exon46 82.22 rat exon46 78.86 
Human exon47 83.67 mouse exon47 78.86 rat exon47 *80 
Human exon48 84.55 mouse exon48 80.15 rat exon48 84.35 
Human exon49 *78 mouse exon49 84.35 rat exon49 86.18 
Human exon50 *78 mouse exon50 80.49 rat exon50 83.13 
Human exon51 *82 mouse exon51 81.93 rat exon51 82.19 
Human exon52 *87 mouse exon52 *82 rat exon52 84 
Human exon53 *77 mouse exon53 82.67 rat exon53 *84 
Human exon54 *67 mouse exon54 *88 rat exon54 *78 
Human exon55 *75 mouse exon55 *78 rat exon55 *67 
Human exon56 *82 mouse exon56 *66 rat exon56 *79 
Human exon57 No hit mouse exon57 *80 rat exon57 *83 
  mouse exon58 *81 rat exon58 no hit  
 
Accordingly, it was shown that most of the exons in human (up until exon 51), 
mouse (up until exon 53) and rat (up until exon 52) TOR also were found on the 
chromosome 8 of zebrafish; and this region laid between the 33,084,667 to 33,434,494 
of the chromosome 8, with an ensemble gene ID of ENSDARG00000006995.  There was 
also a contig sequence in the zebrafish genome to which the human exons from 24 to 51, 
mouse exons from 26 to 53, and rat exons from 25 to 52 showed homology (from 34766 
to 182,105 of the supercontigfinished 202). Particularly interesting was that the 
remaining exons (human52-56,mouse 54-58 and rat 53-57) also were found in this 
supercontig (i.e., from positions 1 to 34766).  However, when walked 34766 bp further 
on the chromosome 8 (i.e, 33,084,667-34766=33,049.901), no homology existed in 
regards to these final five exons. Thus, a conflict was identified between the 1-34766 of 
the supercontig and 33,049,901 – 33,084,667 of the Chromosome 8. 
 
 
 
 
 
                                                                    Human 24-51                             Human 52-56 
Supercontig                                                 Mouse 26-53                               Mouse 54-58 
                                                                    Rat       25-52                                Rat     53-57 
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Part of ch. 8 
Human 1-23,mouse1-25                               Human 24-51, Mouse 26-53 
Rat 1-24                                                        Rat 25-52 
 
 
 
 
 
So DrTOR lies in that region in fact. 
33,232,006 bp 33,434,494 bp 
1.bp 
 
                                  
                                  ENSDARG00000006995                                       ENSDAR
 
When clustalW analysis was performed between the 33,049,901
chromosome 8 and 1-34,766 of Supercontig, 5% homology was 
confirming the idea that there might be a misalignment during contig a
chromosomal level and/or these two genomic sequences come 
chromosomes indicating a truncated duplicate form of TOR. By using the
gene structures (Ensembl ID numbers: ENSDARG00000
ENSDARG00000021164) DrTOR structure was revealed. Based on 
constructed DrTOR sequence, clustalW analysis was performed betwe
mouse, rat and zebrafish TOR genes (Table 4.3 and 4.4). It was shown
TOR has a high similarity with the mammals at the nucleotide level (7634,766 bp182,105 bp33,084,667 bp
33,049,901 bp 
G00000021164 
-33,084,667 of 
found further 
ssembly at the 
from different 
se two ensembl 
006995 and 
the putatively 
en the human, 
 that zebrafish 
 %) and at the 
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protein level (85%).  First part of the genomic sequence of DrTOR also was searched in 
the human genome using VistaPlot software (http://sichuan.lbl.gov/vista/index.shtml). 
The homology between human and putative DrTOR is high; the peaks represent 
homology that is higher than 70% identity were shown in the 1st row. The same region 
of the human was also searched in the mouse and rat genome, and human vs. mouse and 
human vs. rat were shown in the 2nd and 3rd row respectively (Fig. 4.1). 
 
Table 4.3 Pairwise comparisons of TOR cDNA sequences between human, mouse, rat, 
and zebrafish. 
 clustal by clustalW of EBI  
 
Frap/tor Human mouse rat zebrafish
Human 
 1 89% 90% 76% 
Mouse 
 * 1 95% 76% 
Rat 
 * * 1 76% 
Zebrafish 
 * * * 1  
 
Table 4.4 Pairwise comparisons of TOR amino acid sequences between human, mouse, 
rat, and zebrafish 
 clustal by clustalW of EBI  
 
Frap/tor human mouse rat zebrafish
Human 
 1 95% 95% 85% 
Mouse 
 * 1 99% 85% 
Rat 
 * * 1 85% 
Zebrafish 
 * * * 1  
 
  
Fig. 4.1 Vista plots between zebrafish and human (1), and human with rat (2) and human 
with mouse (3). Mammalian TOR sequences and possible DrTOR sequence which was 
found after homology study are analyzed, peaks at the same level show highly similar 
exon sequences.   
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4.2. DrTOR EXPRESSION 
  
4.2.1. Embryonic Gel Expression 
TOR expression was characterized by using reverse transcriptase-PCR 
experiment. Primers were designed to the 3’ end of the gene to increase the efficiency of 
the PCR product, and a 123 bp band was observed by using this primer set.  Expression 
of TOR was observed in the early stages of embryo as in the Fig. 4.2. So, the existence 
of target of rapamycin (TOR) was shown at the transcriptional level. 
 
 
 
 
Fig. 4.2 Expected size of the DrTOR cDNA product and the embryonic expression of 
DrTOR in 12, 16, 20, and 24 hours post fertilized (hpf) embryos with respect to the 
mipep expression. 
 
mipep 
(318 bp) 
 
DrTOR 
(123 bp) 
 
 
4.2.2. Adult Tissue Gel Expression 
TOR expression was also analyzed in different tissues types of the zebrafish. 
RNA isolation was made on neuronal and non-neuronal tissue and constitutive TOR 
expression (except in muscle) was observed according to the mipep expression, (house-
keeping gene) (Fig. 4.3). 
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Fig. 4.3 Adult expression pattern of DrTOR in multiple tissues with respect to Mipep 
expression. cDNA samples: 1) dorsal fin, 2) peripheral fin, 3) gill, 4) ovary, 5) spleen, 6) 
digestive tract, 7) eye, 8) heart,  9) muscle. 
mipep 
( 318bp) 
DrTOR 
(123 bp) 
 
 
4.3. PHENOTYPIC SCREENING  
4.3.1. Larval Growth 
         Larval growth rate was assessed over four days (2, 3, 4, and 5 days post 
fertilization, dpf) in terms of standard length (SL, mm) that spans from the anterior end 
of the upper jaw to the to the end of the hypural plate (Fig. 4.4).  The statistical 
significance of the rapamycin dose and length of exposure on growth has been analyzed 
using One-Way or Two-way ANOVAs (see Appendix for details) at α = 0.05. 
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 Fig. 4.4 An example of the digital photographs used by TPS program to measure the 
body size in terms of Standard Length (SL). Red dots indicate the anterior tip of the 
upper jaw and the end of hypural plate 
 
Zebrafish larvae hatch at around 48-72 hours after fertilization.  The larval length 
at 2 dpf is a mere 3 mm but the larvae rapidly grow over several days (i.e., an additional 
one/fourth of its original size).  The growth rate is relatively linear or even exponential 
at these initial stages although later on in development, rate of growth slows down.   
Initial studies suggested that rapamycin exerted a dose-dependent inhibitory 
effect on the larval growth (Fig. 4.5).  Since rapamycin concentrations less than 1 µM 
did not affect growth rate significantly (Fig. 4.5), a higher concentration of rapamycin 
(i.e., 20 µM in addition to 1 and 2 µM) also was included in the further experiments. 
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Fig. 4.5 Box plots of relative body sizes (standardized to the mean length of the 
untreated control samples) for different doses of rapamycin, i.e., 0 (untreated control) 
and doses ranging between 200 and 2000 nM rapamycin. ANOVA analyses were 
significant both at 3 dpf (F = 6.69, df = 5, p = 0.0027) and 5 dpf (F = 6.03, df = 5, p = 
0.042). 
 
 
 
Accordingly, rapamycin treatment, in addition to significant changes in other 
morphological aspects such as pigmentation and yolk reabsorption, resulted in growth 
inhibition in a dose-dependent manner (Figure 4.6, 4.7).  While the specific control 
groups (i.e., DMSO-only treated larvae; Figure 4.7, diamond shape) exhibited constant 
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growth over this four-day period, rapamycin inhibited the larval growth significantly and 
dose-dependently (Fig.4.7).  Table 4.5 gives a detailed analysis of the changes in body 
size for 1, 2, and 20 µM treatment groups.  Accordingly, the larvae treated with the 
lowest dose (1 µM) of rapamycin did not show any significant differences from its 
control group in terms of the body size (Table 4.7, Fig. 4.7). On the other hand, the 
effects of 2 µM of rapamycin were significantly different from those of the control 
treatment, but only at days 3 and 4 (Table 4.7, Fig. 4.7). The most striking observation 
was that, at the 20 µM, rapamycin almost completely abolished any growth that should 
occur during the period of the experiment (Table 4.7, Fig. 4.7).  This translates into the 
fact that SL of the 20 µM rapamycin-treated 5 days old embryo (2.74 mm) was not 
different from that of the 20 µM rapamycin-treated 2 days old embryo (2.70 mm) while 
it was relatively shorter than the SL of 2 days old control embryo treated with DMSO 
only (2.98 mm).  This reduction when compared with the control was overestimated to 
certain degree due to the fact that one of the embryos in the rapamycin group was 
grossly defective and miniature in size (2.34 mm) when compared to the other two 
individuals.  Although growth arrest properties of rapamycin have been well established 
in model organisms such as the fruitfly and mice, to our knowledge, the present study is 
the first that shows the growth inhibitory effect of rapamycin on the early development 
of zebrafish larvae. 
 
 
  
 
Fig. 4.6 Representative pictures of the control and treatment embryos at 2, 3, and 4 days 
post fertilization (4X Image). 
Control Rapamycin
2 days 3 days
Control
Rapamycin
4 days
Control Rapamycin
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Fig. 4.7 The mean increase in body size (Stan
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 Table 4.5 Body size measurements (i.e., Standard Length, SL; mean ± Standard Error of 
Mean, SEM) of control (DMSO-Rapamycin, SLD-R) and experimental 
(DMSO+Rapamycin, SLD+R) groups treated with three different doses (1, 2, and 20 µM). 
Sample sizes (N), significance of the ANOVA tests, and percentage of the change in 
body size (∆ Size) were shown for 2, 3, 4, and 5 days post fertilization zebrafish 
embryos.    
 
DOSE 
SLD-R ± SEM  
(mm) N 
SLD+R ± SEM 
(mm) N P-Value  ∆ Size (%) 
 
  
2 DAYS 
   
1 µM 2.945 ± 0.039 3 2.958 ± 0.075 3 0.891 0.42 
2 µM 3.134 ± 0.063 3 2.996 ± 0.057 3 0.179 -4.41 
20 µM 2.983 ± 0.081 3 2.696 ± 0.031 3 0.030* -9.63 
   
3 DAYS 
   
1 µM 3.176 ± 0.120 3 3.224 ± 0.009 3 0.709 1.52 
2 µM 3.254 ± 0.013 3 3.092 ± 0.040 3 0.017* -4.98 
20 µM 3.314 ± 0.077 3 2.867 ± 0.075 3 0.014* -13.49 
   
4 DAYS 
   
1 µM 3.543 ± 0.097 2 3.424 ± 0.176 3 0.654 -3.35 
2 µM 3.531 ± 0.036 2 3.175 ± 0.054 2 0.032* -10.08 
20 µM 3.811 ± 0.000 1 2.917 ± 0.069 3 0.023* -23.44 
   
5 DAYS 
   
1 µM 3.704 ± 0.046 3 3.575 ± 0.027 3 0.071 -3.48 
2 µM 3.821 ± 0.121 3 3.631 ± 0.014 2 0.309 -4.99 
20 µM 3.531 ± 0.029 2 2.740 ± 0.206 3 0.059as -22.39 
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 Rapamycin’s dose-specific effects on zebrafish growth rate were found to be 
statistically significant at all the stages examined in this study, i.e., 2, 3, 4, and 5 dpf 
(Fig. 4.8).  In all cases, the slope of the linear regression line was negative indicating 
that growth decreased with increasing rapamycin concentration.  Furthermore, the slope 
ranged between –2.1 and –4.5 %, exhibiting a tendency to further decrease with the 
length of exposure (Fig. 4.8). To statistically analyze the effects of A) dose and B) 
length of exposure/day, a Two-Way ANOVA was performed (Matlab®, anovan).  The 
results showed that while the dose factor was highly significant, the length of 
exposure/day factor was not significant at α = 0.05.  This suggested that the growth 
inhibition by rapamycin was similar at all the developmental stages examined, i.e., 20 
µM dose is significantly more effective than either the 1 or 2 µM doses between the 
second and fifth days of larval development (Table 4.6, Fig. 4.8). Further studies also 
indicated that rapamycin’s dose-dependent effects might be brood-specific.  Indeed, we 
have performed a second set of experiments in which the embryos again were treated 
with 1, 2, and 20 µM rapamycin and larval growth was observed from 2 dpf to 5 dpf.  
Although the effects of rapamycin were highly significant, the rate of growth in control 
embryos was smaller than that took place in the first experiment set (Compare Fig. 4.7 
and Fig. 4.9).   
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Fig. 4.8 Linear regression analysis of growth inhibition (% reduction in Standard Length 
of larvae) over varying rapamycin concentrations (Log2).  The slope and intercept of the 
regressions are shown. 
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Table 4.6 Two-Way ANOVA for the 1st set of experiments; doses include 1, 2, and 20 
µM and days include 2, 3, 4, and 5 dpf. 
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4.3.2. Cranial Cartilage Elements 
 
Neural crest-derived cranial cartilage elements were examined using Alcian Blue 
staining procedure for embryos treated with 2µM and 20µM doses of rapamycin (Fig. 
4.10 and Fig. 4.11, respectively).  The screening for cartilage was used to establish the 
basis for the dose-dependent size reduction observed between the control and rapamycin 
treatment groups.  Furthermore, the cartilage screening allowed for examining the 
presence or absence of the main elements of the cranial cartilage. 
 
The results indicated that all of the cranial cartilage elements that were present in 
the control embryos also were found in the 2 µM rapamycin treated embryos.  
Nevertheless, the size of Meckel’s cartilage, palatoquadrate, hyosymplectic, ceratohyal, 
and branchial arches were comparatively smaller than the control embryos (Fig. 4.10).  
This finding supports the reduction in body size since the skeletal components that make 
up the head are also smaller in the treatment group.  On the other hand, 20 µM 
rapamycin treatment resulted in a more severe phenotype (Fig. 4.11), with apparent 
abnormalities in many of the cranial cartilage elements, e.g., Meckel’s cartilage and  
hyosymplectic, and in some cases missing or underdeveloped cranial structures    
(e.g., branchial arches). 
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 Aig. 4.10 Alcian blue staining of the cranial cartilage elements in control (DMSO only) 
d treatment embryos (DMSO + 2 µM rapamycin).  Cranial elements abbreviated are: 
c, Meckel’s cartilage; Pq, palatoquadrate; Hy, hyoid; Ch, ceratohyal.(A) Control; (B) 
apamycin (2 µM); (C) Comparative: Control (right) and Rapamycin (left).  
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 DCg. 4.11 Alcian blue staining of the cranial cartilage elements in control (DMSO only) 
d treatment embryos (DMSO + 20 µM rapamycin).  Cranial elements abbreviated are: 
c, Meckel’s cartilage; Pq, palatoquadrate; Hy, hyoid; Ch, ceratohyal.(A) Control ; (B) 
pamycin (20 µM); (C) Control; (D) Rapamycin (20 µM). 
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4.3.3. Melanocyte Development and Morphology 
Melanocyte development and morphology have been examined in control and 
rapamycin treated embryos, microscopically.  The embryo and larva have characteristic 
patterns of melanocyte distribution.  The results indicated that rapamycin treatment 
delayed the appearance of pigments in a dose-dependent manner.  Furthermore, once the 
pigments started to migrate along the dorsal and ventral routes, the rate of migration in 
the rapamycin treated embryos was relatively slower and was not as extensive as in the 
control embryos (Fig. 4.12, Fig. 4.13, and Fig. 4.14).  Particularly interesting was that 
the pigmentation around the yolk was extensively reduced in the rapamycin embryos 
when compared with that in the control embryos (Fig. 4.12) 
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Fig. 4.12 Pigmentation and yolk deficiency can be observed at the 2 dpf second set of 
embryos (C: Control, R: Rapamycin treated embryos).  
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Fig. 4.13 Pigmentation and yolk deficiency can be observed at the 3 dpf and 4 dpf  
second set of embryos (C: Control, R: Rapamycin treated embryos). 
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Fig. 4.14 Pigmentation and yolk deficiency can be observed at the 5 dpf second set of 
embryos (C: Control, R: Rapamycin treated embryos). 
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4.4. EFFECTS OF RAPAMYCIN ON GENE EXPRESSION OF SELECTED 
CANDIDATE GENES 
 
4.4.1. Standard Curves and Amplification Efficiencies 
 
Real-time PCR data on a series of ten-fold dilutions of cDNA reverse-transcribed 
from 2 dpf  zebrafish embryos was obtained for amplification of the candidate and 
housekeeping genes used in this study (iCycler, BioRad, Inc. Hercules, CA).  Standard 
curves were generated based on the data presented in Table 4.7.  Theoretically, a 100% 
efficient amplification of a PCR product equals 3.33 cycles.  Our results indicated that 
amplification efficiencies of all of the genes used in this study were close to the 
theoretical value, ranging between 3.17 and 3.64 (Fig. 4.15, Table 4.7). Mipep, 
mitochondrial intermediate peptidase, gene was used as the housekeeping gene in this 
study.  The choice was based on the finding that mipep was one of the genes whose 
mRNA not significantly influenced by rapamycin treatment in yeast (Hardwick et al., 
1999).  
 
Efficiency: [10(-1/slope)-1]*100 
 
Table 4.7 Threshold cycle numbers for the 10X dilution series for the candidate genes 
Conc. (log10) mipep DrTor mitfa 
0 25.8 24.8 25.2 
-1 27.8 27.8 29.1 
-2 32.7 31 32.4 
-3 36.3 34.3 36 
Slope -3.64 -3.17 -3.57 
Efficiency 89% 107% 91% 
 
 
. 
 
 
  
  
Fig. 4.15 Standard curve of the candidate genes used in the study. 
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4.4.2. Real-time RT-PCR Expression Studies 
4.4.2.1. DrTOR 
 
mRNA expression of DrTOR was quantified in an embryonic time-course for 
control and 20 µM rapamycin treated embryos with respect to mipep expression.  The 
embryonic expression profiles of control and rapamycin embryos remained steady, 
however the expression of DrTOR in rapamycin embryos were consistently higher than 
that of the control embryos at all stages of development studied here. (Table 4.8; Fig. 
4.16; Sign-rank test, p =0.03).   
 
Table 4.8 Upregulation of DrTOR in response to rapamycin during early development. 
HOURS Control Rapamycin  Fold Induction (rapamycin/control)
12 0.134 0.435 3.2485 
16 0.072 0.308 4.2869 
20 0.077 0.268 3.4837 
24 0.117 0.268 2.2976 
36 0.058 0.250 4.2882 
48 0.177 0.308 1.7410 
AVERAGE     3.5210  
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Fig. 4.16 Expresssion profile of DrTOR for embryos 12-48 hpf standardized to 8 hpf 
when compared with mipep.  Sign-rank test P =0.03, correlation coefficient between the 
rapamycin and control group is 0.46 (not significant) 
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4.4.2.2. mitfA 
mRNA expression of mitfA was quantified in an embryonic time-course for 
control and 20µM rapamycin treated embryos.  mitfA expression exhibited differences 
during this time course with an increase between 16 and 24 hours of post fertilization.  
In accord with the previous studies (Lister et al., 2002) this period corresponds to the 
induction of mitfA expression at the time of fate determination for the neural crest cells 
to become melanocytes.  The mitfA expression was highly correlated between the control 
and rapamycin embryos over the time period of the study; however, mitfA expression in 
rapamycin embryos was significantly lower than that in the control embryos from 12 
through  48 hours (Table 4.9 ; Fig. 4.17; Sign-rank test, p =0.03). 
 
Table 4.9 Down regulation of mitfA in response to rapamycin during  early development 
HOURS Control Rapamycin 
Inhibition (%) 
(rapamycin/control) 
12 0.041 0.034 -18.69 
16 0.117 0.083 -29.25 
20 9.190 2.639 -71.28 
24 1.231 0.467 -62.11 
36 5.278 3.482 -34.02 
48 6.063 2.639 -56.47 
AVERAGE     -45.30  
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Fig. 4.17 Expresssion profile of mitfA for embryos 12-48 hpf when compared with 
mipep.  Sign-rank test P =0.03 correlation coefficient between the rapamycin and control 
group is 0.98. 
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 Early developmental expression of the mitfA was also measured by using only 8h 
and 48h control and rapamycin treated embryos besides the long time course experiment 
(8, 12, 16, 20, 24, 36, 48 hpf). Result of this shorter experiment confirms the results of 
1st experiment for a decrease in expression of mitfA (table 4.10).   
 
Table 4.10 Fold Change and % inhibition of mRNA expression of mitfA by 
rapamycin for 48 hpf expression over 8 hpf expression results. 
TREATMENT mitfA 
Control 32 
Rapamycin 21.1 
Inhibition (%) -34.0625  
 
These two sets experiments showed that effects of rapamycin on the mRNA 
expression of mitfA were negative and significant (Table 4.11). 
 
Table 4.11 Comparison of inhibition rate of experiment I and experiment II.  
             Inhibition rate 
TREATMENT                    mitfA 
experiment I -45.30% 
experiment II -34.06% 
AVERAGE -39.68%  
 
 
4.5 APPLICATION of siRNA TECHNOLOGY to DrTOR 
 
 siRNA was applied to the embryos before the 2 hpf in E3 medium because  
transportation of RNA from yolk to cells is only possible before the  4-8 cell stage of 
embryo.  The reduction in the expression of DrTOR was only seen in the 40 nM sample, 
and that was not successful to fully eliminate DrTOR mRNA.   
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Table 4.12 Results of the siRNA inhibition study using immersion method. 
TREATMENT FOLD DIFFERENCE RELATIVE TO MEAN CONTROL  
80 nM 1.11 
40 nM 0.32 
Control I  0.97 
Control II 1.04  
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Fig. 4.18 Fold difference of TOR mRNA after siRNA treatment by immersion method.   
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5.  DISCUSSION AND FUTURE PERSPECTIVES 
 
FRAP/TOR is responsible for a multitude of functions necessary for the 
maintenance of cellular homeostasis, and the increased rate of growth and proliferation.  
First discovered in the yeast, FRAP/TOR also has been identified and functionally 
investigated in C.elegans, D. melanogaster, M. musculus, R. norvegicus, and H. sapiens.  
Although the zebrafish, Danio rerio, has already become a highly preferred model 
organism in functional genomics studies, to our knowledge, there is no report in the 
existing literature in regards to either the homology status of the complete cDNA of 
zebrafish TOR (DrTOR), or its mRNA expression or cellular function.  This lack of 
information about DrTOR has been the source of motivation of the present thesis.   
In this study, the full-length cDNA and protein sequence of DrTOR were 
identified and constructed in silico using the public genomic sequences available for 
zebrafish (www.ensembl.org). The results suggested that DrTOR appears to be a single-
copy gene located on the 8th chromosome of the zebrafish.  Although presence of 
duplicate genes is a highly common phenomenon in zebrafish (in teleosts) in comparison 
to mammals, a duplicate full-length DrTOR is unlikely but it is still possible that a 
truncated version may exist. This is because supercontig 22, although highly 
homologous (>95 %) to TOR sequence in chromosome 8, was not assembled with 
chromosome 8. Furthermore, the degree of sequence similarities between the DrTOR 
and the mammalian TORs (those of human, rat, and mouse) were determined using 
phylogenetic analyses (ClustalW and Multalign studies).  These studies suggested a high 
degree of homology between the zebrafish and mammalian Tor proteins. 
 
The mRNA expression of DrTOR has been determined for the first time, using 
an embryonic time-course experiment, and also multiple adult tissues in zebrafish.  
Accordingly DrTOR seemed to be expressed constitutively across all of the 
developmental stages and tissues that were examined. The constitutive expression of 
DrTOR is an expected result since DrTOR is essential in the nutrient sensitive regulation 
of protein translation machinery as well as regulation of cell and body size, which is a 
steady process in the developing embryo.  Especially during early development (before 5 
days post fertilization), zebrafish uses its yolk for nutrients, thus this constant supply of 
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yolk requires TOR signaling to be efficiently consumed.  Accordingly, one may suggest 
that the quality and quantity of the yolk material may indeed be the nutrient signal that 
regulates the activity of the Tor protein in zebrafish.  This could be tested further by 
experiments that involve the removal of yolk during embryogenesis to see its effects on 
DrTOR expression both at the mRNA and protein levels.  Alternatively, embryos from 
nutritionally deficient parents and those from adequately fed parents could be compared 
in terms of the expression of TOR signaling components and associated growth 
parameters. 
Previously, rapamycin has been shown to specifically inhibit the kinase activity 
of Tor protein in various eukaryotes.  The observed high sequence homology of DrTOR 
to mammalian Tor proteins suggested that DrTOR function also was likely to be 
conserved in zebrafish.  Once the mRNA expression of DrTOR was confirmed to occur 
during embryogenesis, different concentrations of rapamycin have been used to inhibit 
TOR function in 2 to 5 days post fertilized embryos.  The primary expected result of 
rapamycin exposure in zebrafish would be a decrease in body size in a dose-dependent 
manner in line with the experiments done in other organisms.  Indeed, the embryonic 
and larval body size was significantly reduced; and this reduction was dependent on the 
dose of rapamycin used.  At 2 µM of rapamcyin treatment, there was up to a 10% 
decrease in 4 dpf embryos, whereas at 20µM rapamycin resulted in a much greater 
degree of inhibition (up to 23%) that could be defined as complete growth arrest.  
However, there was an indication that 0.4 % DMSO alone may result in a minor growth 
reduction as observed in the control group of 20 µM DMSO at day 5.  An ANOVA 
performed on the standard length measurements from all control groups at day 5 showed 
that this observed reduction at day 5 was not significant at α = 0.05 (Experiment I day 5; 
p = 0.17).  However, further experiments may consider using a lower dose of rapamycin 
(10 µM) to reduce the unwanted effects of DMSO, which is necessary to dissolve the 
rapamycin. Furthermore, rapamycin may be dissolved in a smaller amount of DMSO 
such as 20 µl to make a stock solution with higher rapamycin concentrations.  In order to 
fully understand the toxicity of rapamycin in zebrafish, an IC50 should also be 
determined. The findings of the present thesis support rapamycin’s teratogenic effects as 
shown in mice (Hentges et al., 2001). 
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The body size measurements were made as standard length, which provides 
information about the changes in the axis of the embryo.  During early development, the 
body size may increase up to 1/4th of the initial size of the embryo due the establishment 
and expansion of the cranial elements and vertebral structures.  Therefore, the formation 
and condensation of the cranial cartilages that make up most of the head skeleton also 
were studied. A size reduction was apparent in all of the elements that could be 
identified by alcian blue staining at the dose of 2 µM, although no missing elements 
were observed. On the other hand, at 20 µM rapamycin, the Meckel’s cartilage, 
ceratohyal, and hyoid were severely deformed, and the branchial arches did not take up 
the dye, indicating their poor formation and/or arrested development.  Further replicated 
studies are needed to quantify the extent of reduction and changes in the morphology of 
the deformations observed in these initial phenotypic screening studies. Shegogue and 
Trojanowska (2004) have recently showed the negative relationship between the 
rapamycin exposure and collagen synthesis due to decreases on col1a1 expression.  
Effects of rapamycin on col2a1 and its transcriptional activators such as Sox9a (Yan et 
al., 2002) also should be explored since the findings of this thesis showed extensive 
retardation in cranial cartilage formation.    
    Another apparent morphological change was a significant reduction in the amount 
of pigmentation and its aberrant migration pattern.  Particularly, the pigmentation around 
the yolk has been significantly reduced, and in the rapamycin embryos no pigments were 
located at the ventral areas of the yolk, which is one of the locations for melanocytes 
according to stereotypic larval pigment patterns.   
These findings were interesting in that, at least two of the neural crest derived 
structures, i.e., cranial cartilages and the melanocytes, were the most affected structures 
in the zebrafish embryos exposed to rapamycin.  Thus, they have provided the 
motivation to investigate candidate genes that were known to participate in the fate 
determination and migration of neural crest cells.  The selected gene, mitfA is actively 
regulated during melanogenesis. Use of bioinformatics methods, such as VxInsight 
generated data, also helped to narrow down on the selection of candidate gene since 
mitfA was characterized as being co-regulated by TOR expression.  A combined 
approach involving the results of phenotypic screening and bioinformatics allowed for 
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insights in novel gene function discovery and deciphering the highly connected genetic 
networks around the DrTOR. 
The mRNA expression of mitfA was highly correlated between the control and 
20 µM rapamycin treated embryos (r = 0.98).  This information was important in testing 
the accuracy of the real time RT-PCR results, since such a high correlation from two 
independent sets of embryonic experiments is not likely to occur randomly.  
Furthermore, the expression pattern closely followed the phenotypic changes that occur 
in the embryo.  The neural crest cells start gaining their melanogenic fates from 
approximately 16 hpf at 28.5 °C.  This was exactly the time period in the present 
experiments where mitfA expression increased drastically in both the control and 
rapamycin embryos followed by a significant reduction at 24 hpf.  Another steady 
increase was observed after 36 hpf, which continued towards the 48th hours.  
Interestingly, the similarity in the general pattern of mitfA expression between two 
groups suggested that the rapamycin embryos also go through the stereotypical 
developmental timing processes with the control embryos.  However, the amount of 
induction was not near to the extent the control embryos experienced.  This might be due 
to that an upstream component in the mitfA signaling being inhibited due to Tor 
inhibition by rapamycin. Or alternatively, mitfA itself may be directly in the downstream 
of TOR and rapamycin resulted in the downregulation of its expression.  Previous 
studies have indicated that c-kit, which act upstream of Mitf, is influenced by rapamycin 
treatment (Feng et al., 2000).  Therefore, the inhibition of c-kit expression or function is 
likely to occur in zebrafish, as well. Further studies should be designed to investigate the 
participation of c-kit in the TOR signaling in zebrafish.  Changes in the mitfA expression 
profile may be affected by the circadian rhythm of the embryos.  Zebrafish have been on 
a day/night cycle during the experiments (14h light/10h dark). Accordingly, lights were 
turned off at 24:00 when embryos were 14 hours old, and came back at 10.00 when 
embryos reached the 24 hpf stage.  In this respect, the highest increase in the mitfA 
expression occured between the 16 and 20th hours of the development (Fig. 27) and at 
dark period. However, a sharp decrease in the expression of mitfA was observed from 
20th to 24th hours of development; and at 24 hpf mitfA expression started to rise once 
again to remain steady later in the development.  However, due to lack of samples taken 
at shorter intervals between the 24th to 48th hours of development, it was not possible to 
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test the presence of cyclic fluctuations in mitfA expression during zebrafish late 
embryogenesis.   
   
On the other hand, DrTOR expression in the control and rapamycin experiments 
remained rather steady over the embryonic developmental course (12-48 hpf).  This is in 
accord with DrTOR being constitutively expressed for the maintenance of cell growth 
and division.  However, rapamycin treated embryos exhibited a generally higher level of 
DrTOR expression when compared with the control embryos (p = 0.03).  This suggested 
that DrTOR might have an auto control mechanism such that when the activity of 
DrTOR is reduced, (A) its expression could be positively feed-backed; or (B) the 
downstream effectors of DrTOR, possibly involved in negative regulation of DrTOR 
expression, fail to relay the inhibitory signal to the transcription factors controlling 
DrTOR expression.  
 
siRNA experiments are relatively recent in fish. There are only two research 
groups that investigated and published their results so far. These studies used the 
microinjection method.  In a pilot study, the potential of the immersion method in 
zebrafish was investigated due to the encouraging results obtained from cell culture 
studies as well as whole organism studies such as in C. elegans.  The results indicated 
that immersion method in zebrafish did not work at the concentrations and/or the 
methodology that is proposed in this experiment (40 and 80 nM).  Although there was a 
4-fold reduction of DrTOR expression at the 40 nM siRNA treatment embryos, 80 nM 
siRNA embryos did not show any reduction in the DrTOR expression.  Since the degree 
of penetrance (% of individuals that take-up and respond to an inhibitory molecule) is a 
known variable in the knock-down studies, further experiments are need to conclude that 
immersion method indeed is not sufficient for successful inhibition by siRNA in 
zebrafish.  Further improvements in the method may involve the use of liposomes or 
CaCl2 for successful transfection. 
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APPENDICES: 
 
APPENDIX A:  
MATLAB CODE; 
 
function 
[landmark,samplelabel,specdist,grplabel,correctdist,ori,conc,descstato,descstat,no,n]=rea
dland1(filename,n1,n2,n3) 
tline1=[] 
tline2=[] 
count=0 
count2=0 
%OPEN COORDINATE FILE 
fid=fopen(filename,'rt') 
%READ THE APPENDED COORDINATES, SAVE THE NAME OF THE SAMPLE 
and COORDINATES IN LANDMARK structure  
    while feof(fid)==0 
    tline=fgetl(fid); 
        if ~isempty(findstr(tline,'LM')) 
            count=count+1; 
            landmark(count).numland=tline; 
            tline1=[]; 
            count2=0; 
             
        elseif ~isempty(findstr(tline,'IMAGE')) 
        landmark(count).samplename=tline; 
         
        elseif isempty(findstr(tline,'LM')) 
            count2=count2+1; 
            landmark(count).coordin{count2}=tline; 
         
        end 
    end 
specdist=zeros(count,1); 
%FOR EACH SAMPLE AND ITS MAP CALCULATE THE EUCLEDIAN 
DISTANCE 
    for i=1:count 
        [g,z]=size(landmark(i).coordin); 
        allcoor=zeros(z,2); 
        for j=1:z 
            allcoor(j,1:2)=str2num(landmark(i).coordin{j}); 
         
        end 
        landmark(i).distance=dist(allcoor'); 
        if ~isempty(findstr(landmark(i).numland,'LM=3')) 
        specdist(i)=landmark(i).distance(n1,n3); 
        else 
        specdist(i)=landmark(i).distance(n1,n2); 
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        end 
    end 
    %GENERATE A SAMPLE LABEL FOR EACH SAMPLE  
samplelabel=zeros(count,1); 
for i=1:count 
        % 11 indicates dmso 1uM 
    if ~isempty(findstr(landmark(i).samplename,'IMAGE=C1.')) 
        samplelabel(i)=11; 
        % 12 indicates dmso 2uM 
    elseif ~isempty(findstr(landmark(i).samplename,'IMAGE=C2.')) 
        samplelabel(i)=12; 
        % 120 indicates dmso 20uM 
    elseif ~isempty(findstr(landmark(i).samplename,'IMAGE=C20.')) 
        samplelabel(i)=120; 
        % 21 indicates dmso+rapa 1 uM 
    elseif ~isempty(findstr(landmark(i).samplename,'IMAGE=R1.')) 
        samplelabel(i)=21; 
        % 22 indicates dmso+rapa 2 uM 
    elseif ~isempty(findstr(landmark(i).samplename,'IMAGE=R2.')) 
        samplelabel(i)=22; 
        % 220 indicates dmso+rapa 20uM 
    elseif ~isempty(findstr(landmark(i).samplename,'IMAGE=R20.')) 
        samplelabel(i)=220; 
    end 
end 
 
ls=length(specdist); 
grplabel=samplelabel(1:2:ls); 
% CONVERT SAMPLE PIXELS INTO MM USING THE MAP PIXELS 
correctdist=(specdist(2:2:ls).*sqrt(2))./specdist(1:2:ls); 
% ANOVA FOR 1uM 
la11=find(grplabel==11); 
la21=find(grplabel==21); 
[p,anovatab,stats]=anova1([correctdist(la11);correctdist(la21)],[grplabel(la11);grplabel(l
a21)]); 
 
     
% ANOVA FOR 2uM 
la12=find(grplabel==12); 
la22=find(grplabel==22); 
[p,anovatab,stats]=anova1([correctdist(la12);correctdist(la22)],[grplabel(la12);grplabel(l
a22)]);   
     
% ANOVA FOR 20uM 
la120=find(grplabel==120); 
la220=find(grplabel==220); 
[p,anovatab,stats]=anova1([correctdist(la120);correctdist(la220)],[grplabel(la120);grplab
el(la220)]); 
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% ANOVA FOR CONCENTRATION CURVE, three groups, each group is 
standardized to its mean dmso control value 
oridata=[correctdist(la21);correctdist(la11);correctdist(la22);correctdist(la12);correctdist
(la220);correctdist(la120)]; 
origrp=[grplabel(la21);grplabel(la11);grplabel(la22);grplabel(la12);grplabel(la220);grpla
bel(la120)]; 
ori=[origrp oridata]; 
figure 
[mo,so,co,no]=grpstats(oridata,origrp,0.05); 
descstato=[mo,so,co]; 
concdata=[correctdist(la21)./mean(correctdist(la11));correctdist(la22)./mean(correctdist(
la12));correctdist(la220)./mean(correctdist(la120))]; 
concgrp=[ones(length(la21),1)*1;ones(length(la22),1)*2;ones(length(la220),1)*20]; 
conc=[concgrp concdata]; 
[p,anovatab,stats]=anova1(concdata,concgrp); 
title('Concentration curve') 
figure 
comparison=multcompare(stats) 
figure 
[m,s,c,n]=grpstats(concdata,concgrp,0.05) 
descstat=[m,s,c]; 
 
%[p,anovatab,stats]=anova1(correctdist,grplabel); 
%figure 
%comparison=multcompare(stats) 
%figure 
%[m,s,c,n]=grpstats(correctdist,grplabel,0.05) 
%descstat=[m,s]; 
%return 
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